Home Contact Sitemap

eRAM

encyclopedia of Rare Disease Annotation for Precision Medicine




Disease portal hypertension
Comorbidity C0020538|hypertension
Sentences 7
PubMedID- 20677289 Pulmonary arterial hypertension (pah) associated with portal hypertension [portopulmonary hypertension (pphtn)] occurs in 2% to 10% of patients with advanced liver disease and carries a very poor prognosis without treatment.
PubMedID- 23982562 This review summarizes the clinicopathologic features, diagnostic criteria, as well as the latest concepts in the pathogenesis and management of poph, which is defined as is a form of pulmonary arterial hypertension (pah) associated with portal hypertension with or without underlying chronic liver disease.
PubMedID- 19766269 Children with congenital portosystemic venous shunt (psvs) are at risk for developing pulmonary hypertension, irrespective of the severity of portal hypertension or liver damage.
PubMedID- 21828952 Pulmonary arterial hypertension (pah) in patients with portal hypertension is also referred to as portopulmonary hypertension (pphtn).
PubMedID- 25653708 Hepatopulmonary syndrome (hps) and portopulmonary hypertension (pphtn) are complications of portal hypertension and cirrhosis.
PubMedID- 24046802 We report a case of acute right heart pressure overload after surgical correction of the suprahepatic inferior vena cava anastomotic stricture in a 54-year-old woman who had preexisting pulmonary arterial hypertension associated with portal hypertension after orthotopic liver transplantation.
PubMedID- 26029592 Poph is defined as pulmonary arterial hypertension with portal hypertension in the absence of other causes of pulmonary arterial hypertension.

Page: 1